Aesthetic Medical International Holdings Group Ltd.
| 0.7996 | +0.0497 | +6.63% | Vol 511 | 1Y Perf -56.65% |
| Oct 3rd, 2023 15:38 DELAYED |
| BID | 0.6325 | ASK | 0.7995 | ||
| Open | 0.7735 | Previous Close | 0.7499 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 10.00 | Analyst Rating | — 0.00 | |
| Potential % | 1.15K | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ☆ 32.38 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★ 36.40 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 16.21 | Earnings Rating | — | |
| Market Cap | 25.07M | Earnings Date | 6th Sep 2023 | |
| Alpha | -0.03 | Standard Deviation | 0.20 | |
| Beta | -0.07 |
Today's Price Range 0.76350.7996 | 52W Range 0.61001.78 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 6.63% | ||
| 1 Month | 11.10% | ||
| 3 Months | -21.61% | ||
| 6 Months | -37.53% | ||
| 1 Year | -56.65% | ||
| 3 Years | -82.95% | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -146.17 | |||
ROE last 12 Months | 660.94 | |||
ROA (5Y Avg) | -17.76 | |||
ROA last 12 Months | -109.01 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -90.36 | |||
Return on invested Capital Q | -35.69 | |||
Return on invested Capital Y | -101.73 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 3.80 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -0.30 | ||||
| 2.30 | ||||
| 1.94 | ||||
| 4.90 | ||||
| 9.30 | ||||
| 0.28 | ||||
| -3.22 | ||||
| -0.44 | ||||
| 101.91M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.10 | ||||
| 0.20 | ||||
| 0.62 | ||||
| 2.90 | ||||
| -29.50 | ||||
| Leverage Ratio | -4.30 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 44.20 | ||||
| -99.20 | ||||
| -99.20 | ||||
| -24.50 | ||||
| -31.38 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 23.47M | ||||
| 0.75 | ||||
| -5.11 | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q02 2023 | - | -0.03 | - |
| Q03 2022 | - | -0.01 | - |
| Q03 2021 | - | -0.10 | - |
| Q02 2021 | - | -0.10 | - |
| Q01 2021 | - | -0.04 | - |
| Q04 2020 | - | -0.17 | - |
| Q03 2020 | - | 0.06 | - |
| Q02 2020 | - | -0.20 | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 511 |
| Shares Outstanding | 31.35K |
| Shares Float | 280.96K |
| Trades Count | 4 |
| Dollar Volume | 400 |
| Avg. Volume | 7.39K |
| Avg. Weekly Volume | 3.51K |
| Avg. Monthly Volume | 11.52K |
| Avg. Quarterly Volume | 7.15K |
Aesthetic Medical International Holdings Group Ltd. (NASDAQ: AIH) stock closed at 0.7996 per share at the end of the most recent trading day (a 6.63% change compared to the prior day closing price) with a volume of 511.0000 shares and market capitalization of 25.07M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1550 people. Aesthetic Medical International Holdings Group Ltd. CEO is Zhou Pengwu.
The one-year performance of Aesthetic Medical International Holdings Group Ltd. stock is -56.65%, while year-to-date (YTD) performance is -38.02%. AIH stock has a five-year performance of %. Its 52-week range is between 0.61 and 1.78, which gives AIH stock a 52-week price range ratio of 16.21%
Aesthetic Medical International Holdings Group Ltd. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 2.30, a price-to-sale (PS) ratio of 1.94, a price to cashflow ratio of 4.90, a PEG ratio of -, a ROA of -109.01%, a ROC of -90.36% and a ROE of 660.94%. The company’s profit margin is -31.38%, its EBITDA margin is -99.20%, and its revenue ttm is $23.47 Million , which makes it $0.75 revenue per share.
Of the last four earnings reports from Aesthetic Medical International Holdings Group Ltd., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Aesthetic Medical International Holdings Group Ltd.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Aesthetic Medical International Holdings Group Ltd. is — (0), with a target price of $10, which is +1 150.63% compared to the current price. The earnings rating for Aesthetic Medical International Holdings Group Ltd. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Aesthetic Medical International Holdings Group Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Aesthetic Medical International Holdings Group Ltd. has a Neutral technical analysis rating based on Technical Indicators (ADX : 29.73, ATR14 : 0.07, CCI20 : 32.69, Chaikin Money Flow : 0.06, MACD : 0.00, Money Flow Index : 76.45, ROC : 2.50, RSI : 52.33, STOCH (14,3) : 42.99, STOCH RSI : 0.60, UO : 41.82, Williams %R : -57.01), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Aesthetic Medical International Holdings Group Ltd. in the last 12-months were:
Aesthetic Medical International Holdings Group Ltd.
Aesthetic Medical International Holdings Group Ltd provides aesthetic medical services in China. The company generates revenue from three service offerings: non- surgical aesthetic medical services, comprising minimally invasive aesthetic treatments and energy-based treatments; surgical aesthetic medical services, and general healthcare services and other aesthetic medical services. Most of the firm's revenue gets derived from Non-surgical aesthetic medical services. Geographically, it derives revenue from China.
CEO: Zhou Pengwu
Telephone: +86 75525598065
Address: No. 1122, Nanshan Boulevard, Shenzhen 518052, , CN
Number of employees: 1 550
